Experimental cancer drug ZW171 tested in 32 patients, but study stopped early
NCT ID NCT06523803
First seen Oct 31, 2025 · Last updated Jun 12, 2026 · Updated 34 times
Summary
This early-phase study tested a new drug called ZW171 in 32 people with advanced ovarian, lung, or other cancers that have a protein called mesothelin. The main goals were to check the drug's safety and find the right dose. The study was terminated early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MESOTHELIN-EXPRESSING ADVANCED CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Guys and St Thomas' NHS Foundation Trust
London, SE1 9RT, United Kingdom
-
Icahn School of Medicine at Mount Sinai (ISMMS) - The Blavatnik Family-Chelsea Medical Center
New York, New York, 10011, United States
-
Norton Cancer Institute
Louisville, Kentucky, 40202, United States
-
Royal Marsden Hospital
Sutton, SW3 6JJ, United Kingdom
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Sarah Cannon Research Institute
Nashville, Tennessee, 37203, United States
-
Seoul National University Hospital
Seoul, 03080, South Korea
-
The Catholic University of Korea, Seoul St. Marys Hospital
Seoul, South Korea
-
The Christie NHS Foundation Trust
Manchester, M20 4BX, United Kingdom
-
UPMC Hillman Cancer Center
Pittsburgh, Pennsylvania, 15232, United States
-
Universitaetsklinikum Dresden
Dresden, 01307, Germany
-
University of Colorado Health Sciences Center
Aurora, Colorado, 80045, United States
-
University of Southern California - Norris Comprehensive Cancer Center
Los Angeles, California, 90089, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
Yonsei University Health System - Severance Hospital
Seoul, 03722, South Korea
Conditions
Explore the condition pages connected to this study.